Table 1.
Overview of patient collective.
| Diagnosis | N | Age (Mean) | Gender ♂:♀ | Bile Samples | Plasma Samples | Tissues | CA19-9 (U/mL) |
|---|---|---|---|---|---|---|---|
| Localized disease | 16 | 66.5 | 8:8 | 9 | 14 | 13 | 856.1 |
| CCA | 6 | 62.5 | 4:2 | 2 | 5 | 5 | 112.0 |
| PDAC | 10 | 70.8 | 4:6 | 6 | 8 | 8 | 1302.6 |
| Metastatic disease | 29 | 64.6 | 18:11 | 13 | 24 | 16 | 3725.1 |
| CCA | 4 | 58.0 | 2:2 | 2 | 3 | 4 | 4235.5 |
| PDAC | 25 | 65.6 | 16:9 | 11 | 21 | 12 | 3655.6 |
| Control | 35 | 63.7 | 20:15 | 23 | 14 | - | 93.5 |
| CBD obstruction | 10 | 69.5 | 7:3 | 10 | 0 | - | 126.7 |
| Choledocholithiasis | 4 | 80.0 | 0:4 | 4 | 1 | - | - |
| Chronic pancreatitis | 7 | 50.1 | 5:2 | 3 | 4 | - | 53.1 |
| IPMN | 6 | 72.5 | 1:5 | 1 | 5 | - | 17.7 |
| PSC | 5 | 49.0 | 3:2 | 5 | 1 | - | 130.0 |
| Pseudocyst | 5 | 63.0 | 4:1 | 1 | 4 | - | 6.7 |
CCA: cholangiocarcinoma; PDAC: pancreatic ductal adenocarcinoma; CBD: common bile duct; IPMN: intraductal papillary mucinous neoplasm; PSC: primary sclerosing cholangitis. Bold: the sum of the sections.